Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

被引:0
|
作者
Acar, Ibrahim Halil [1 ]
Atalay, Figen [2 ]
Demirsoy, Esra Terzi [3 ]
Can, Ferda [4 ]
Guven, Zeynep Tugba [5 ]
Cetiner, Mustafa [6 ]
Tombak, Anil [7 ]
Comert, Melda [8 ]
Guvenc, Birol [1 ]
机构
[1] Cukurova Univ, Dept Hematol, Dept Internal Med, Fac Med, Adana, Turkiye
[2] Baskent Univ, Istanbul Hosp, Hematol Clin, Ankara, Turkiye
[3] SBU Kocaeli Derince Training & Res Hosp, Hematol Clin, Kocaeli, Turkiye
[4] Ankara City Hosp, Hematol Clin, Ankara, Turkiye
[5] Erciyes Univ, Dept Hematol, Dept Internal Med, Fac Med, Kayseri, Turkiye
[6] Acibadem Maslak Hosp, Hematol Clin, Istanbul, Turkiye
[7] Mersin Univ, Dept Hematol, Dept Internal Med, Fac Med, Mersin, Turkiye
[8] SBU Gulhane Training & Res Hosp, Hematol Clin, Istanbul, Turkiye
来源
关键词
MDS; myelodysplastic syndrome; darbepoetin alfa;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDS-143
引用
下载
收藏
页码:S354 / S354
页数:1
相关论文
共 50 条
  • [21] Characteristics of surgically treated Guyon canal syndrome: A multicenter retrospective study
    Lee, Jae Hoon
    Lee, Jun-Ku
    Park, Jin Sung
    Kim, Dong Hee
    Baek, Jong Hun
    Yoon, Byung-Nam
    Kim, Segi
    Ha, Cheungsoo
    Cho, Weong Min
    Han, Soo -Hong
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2022, 75 (09): : 3269 - 3278
  • [22] Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan
    Motoshi Hattori
    Osamu Uemura
    Hiroshi Hataya
    Shuichi Ito
    Masataka Hisano
    Toshiyuki Ohta
    Shuichiro Fujinaga
    Tomoo Kise
    Yoshimitsu Gotoh
    Akira Matsunaga
    Naoko Ito
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2014, 18 : 634 - 641
  • [23] Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study
    Villegas, Ana
    Arrizabalaga, B.
    Fernandez-lago, C.
    Mouzo, M.
    Mayans, Jr
    Gonalez-Porras, Jr
    Duarte, Rafael
    Remacha, Angel Francisco
    Luno, Elisa
    Gasquet, J. A.
    BLOOD, 2008, 112 (11) : 1184 - 1184
  • [24] Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan
    Hattori, Motoshi
    Uemura, Osamu
    Hataya, Hiroshi
    Ito, Shuichi
    Hisano, Masataka
    Ohta, Toshiyuki
    Fujinaga, Shuichiro
    Kise, Tomoo
    Gotoh, Yoshimitsu
    Matsunaga, Akira
    Ito, Naoko
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (04) : 634 - 641
  • [25] The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study
    Ak, Muzeyyen Aslaner
    Sahip, Birsen
    Geduk, Ayfer
    Ucar, Mehmer Ali
    Kale, Hacer
    Hacibekiroglu, Tugba
    Polat, Merve Gokcen
    Kalpakci, Yasin
    Bolaman, Ali Zahit
    Guvenc, Birol
    Ertop, Sehmus
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (02) : 299 - 308
  • [26] The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study
    Muzeyyen Aslaner Ak
    Birsen Sahip
    Ayfer Geduk
    Mehmer Ali Ucar
    Hacer Kale
    Tugba Hacibekiroglu
    Merve Gokcen Polat
    Yasin Kalpakci
    Ali Zahit Bolaman
    Birol Guvenc
    Sehmus Ertop
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 299 - 308
  • [27] Retrospective study of the efficacy of darbepoetin alfa in the correction of anaemia in chronic hemodialysis patients
    Mansour, Janette
    Fickl, Rocsana
    Ebikili, Bertin
    Hardin, Jean-Michel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 157 - 157
  • [28] Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response
    Villegas, A.
    Arrizabalaga, B.
    Fernandez-Lago, C.
    Castro, M.
    Mayans, J. R.
    Gonzalez-Porras, J. R.
    Duarte, R. F.
    Remacha, A. F.
    Luno, E.
    Gasquet, J. A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 951 - 960
  • [29] Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study
    Cho, Minkwan
    Park, Eunkyung
    Lee, Yong-Pyo
    Kim, Hongsik
    Park, Hee Sue
    Kim, Hee Kyung
    Yang, Yaewon
    Kwon, Jihyun
    Lee, Ki Hyeong
    Han, Hye Sook
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [30] Clinical characteristics and outcomes of nosocomial COVID-19 in Turkey: A retrospective multicenter study
    Yildirim, Suleyman
    Yilmaz, Celalettin
    Polat, Gulru
    Baris, Serap
    Basyigit, Ilknur
    Kaya, Ilknur
    Anar, Ceyda
    Bozkurt, Mihriban
    Baykal, Huesnue
    Dirol, Hulya
    Ozbey, Gamzenur
    Ozsari, Emine
    Cireli, Emel
    Ciirak, Ali
    Tatar, Dursun
    Gayaf, Mine
    Karaoglanoglu, Selen
    Aydin, Yener
    Eroglu, Atilla
    Olcar, Yildiz
    Yildirim, Berna
    Gursoy, Bengul
    Yilmaz, Deniz
    Niksarlioglu, Elif
    Eren, Ramazan
    Erdem, Aysegul
    Tor, Muge Meltem
    Fakili, Fusun
    Colak, Mustafa
    Ercelik, Merve
    Tabaru, Ali
    Ediboglu, Ozlem
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2023, 16 (08) : 347 - 353